Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
There is an unsatisfied medical need for a first-line treatment of localized uncomplicated
proliferating Infantile Hemangioma with a good benefit/risk profile.
Pierre Fabre Dermatologie has developed a new formulation of propranolol (V0400 GL 01A) which
is a topical gel adapted to paediatric use.
The objective of this study is to evaluate topical propranolol efficacy and safety in the
management of localized hemangioma.
Phase:
Phase 2
Details
Lead Sponsor:
Pierre Fabre Dermatology
Treatments:
Molecular Mechanisms of Pharmacological Action Propranolol